医学
ADAMTS13号
血栓性血小板减少性紫癜
分裂细胞
基因检测
血栓性微血管病
溶血性贫血
疾病
免疫学
罕见病
突变
内科学
血小板
基因
遗传学
生物
作者
Kirk D. Wyatt,Mira A. Kohorst,Lea M. Coon,Rachel M. Hurley,H.A. van Dorland,Carola A.S. Arndt
标识
DOI:10.1097/mph.0000000000001830
摘要
Hereditary thrombotic thrombocytopenic purpura is an ultra-rare disorder caused by biallelic mutations in the ADAMTS13 gene. Because it can be difficult to diagnose, plasma ADAMTS13 activity assessment should be considered in patients with thrombocytopenia, anemia, and schistocytes on peripheral blood smear. We present the diagnostic evaluation of a patient with hereditary thrombotic thrombocytopenic purpura. Genetic testing revealed one known pathogenic mutation and one novel mutation of ADAMTS13 classified as likely pathogenic on the basis of parental genetic testing and in silico analyses. We further discuss off-label use of prophylactic plasma-derived Factor VIII (Koate-DVI) and the benefit of rare disease registries.
科研通智能强力驱动
Strongly Powered by AbleSci AI